Sentence examples for most commonly resistant from inspiring English sources

Presently, the antimicrobial agents to which this serovar is most commonly resistant are ceftriaxone (a drug of choice for treatment), along with resistance to streptomycin, tetracycline, sulfamethoxazole, chloramphenicol, and trimethoprim-sulfamethoxazole (NARMS 2010).

S. enterica Typhimurium isolates tested were most commonly resistant to ampicillin (90.3%, 56/62), followed by tetracycline (80.6%, 50/62), trimethoprim/sulfamethoxazole (74.2%, 46/62) and chloramphenicol (66.1%, 41/62).

Phenotypes in both groups were most commonly resistant to tetracycline and sulfamethoxazole/tetracycline.

In contrast, Streptomyces isolates were most commonly resistant to antibiotic inhibition by an intermediate number of other isolates.

E. coli was the most common microorganism detected both in northern areas (CC1, CC2, CC3, CC4) and in central-southern areas (CC5, CC6, CC7, CC8), but while in northern LTCFs it was also the most frequent BL-producer, the most commonly resistant strain in central-southern LTCFs was P. mirabilis.

1 Resistance to penicillinase-resistant penicillins was first recognised more than 50 years ago, 2 and today methicillin-resistant S. aureus (MRSA) is among the most commonly identified resistant nosocomial infections worldwide.

12 Data from a randomized clinical trial comparing frequency and patterns of resistance between nevirapine IR and nevirapine XR (VERxVe trial) showed similar frequency and resistance patterns in both antiretroviral-treatment regimens, Y181C being the most commonly detected resistant mutation.

Given the risk of emergence of resistant pathogens due to widespread vancomycin use and the often relatively indolent course of infections due to the most commonly isolated resistant Gram-positive organisms (i.e., CNS), routinely adding vancomycin to the first-line regimen is now strongly discouraged in stable patients [1, 2, 28].

Given the risk of emergence of resistant pathogens due to widespread vancomycin use and the often relatively indolent course of infections due to the most commonly isolated resistant Gram-positive organisms (i.e., CNS), routinely adding vancomycin to the first-line regimen is now strongly discouraged in stable patients [ 1, 2, 28].

Major pathogens were identified in 49% of patients, most commonly methicillin-resistant Staphylococcus aureus (14.8%) and Pseudomonas aeruginosa (14.3%).

S. aureus strains that were resistant against PEN most commonly demonstrated isolated resistant against PEN, but did show secondary resistances against three other AB, mainly AZITH, ERY and CLIND (Table  4).